Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment

Title
Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment
Authors
Keywords
Avelumab, PD-L1, resistance, Cxcl9, tumor associated macrophage, scRNA-Seq
Journal
Cell Reports
Volume 32, Issue 1, Pages 107873
Publisher
Elsevier BV
Online
2020-07-07
DOI
10.1016/j.celrep.2020.107873

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now